Literature DB >> 10668461

Mitochondrial membrane permeabilization during the apoptotic process.

E Jacotot1, P Costantini, E Laboureau, N Zamzami, S A Susin, G Kroemer.   

Abstract

Apoptosis may be viewed as a triphasic process. During the pre-mitochondrial initiation phase, very different pro-apoptotic signal transduction or damage pathways can be activated. These pathways then converge on the mitochondrion, where they cause the permeabilization of the inner and/or outer membranes with consequent release of soluble intermembrane proteins into the cytosol. The process of mitochondrial membrane permeabilization would constitute the decision/effector phase of the apoptotic process. During the post-mitochondrial degradation phase downstream caspases and nucleases are activated and the cell acquires an apoptotic morphology. Recently, a number of different second messengers (calcium, ceramide derivatives, nitric oxide, reactive oxygen species) and pro-apoptotic proteins (Bax, Bak, Bid, and caspases) have been found to directly compromise the barrier function of mitochondrial membranes, when added to isolated mitochondria. The effects of several among these agents are mediated at least in part via the permeability transition pore complex (PTPC), a composite channel in which members of the Bcl-2 family interact with sessile transmembrane proteins such as the adenine nucleotide translocator. These findings suggest that the PTPC may constitute a pharmacological target for chemotherapy and cytoprotection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668461     DOI: 10.1111/j.1749-6632.1999.tb07919.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  29 in total

1.  Spatial profiles of store-dependent calcium release in motoneurones of the nucleus hypoglossus from newborn mouse.

Authors:  Thomas Ladewig; Peter Kloppenburg; Peter M Lalley; Warren R Zipfel; Watt W Webb; Bernhard U Keller
Journal:  J Physiol       Date:  2003-01-24       Impact factor: 5.182

Review 2.  Autophagy in cell death: an innocent convict?

Authors:  Beth Levine; Junying Yuan
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 3.  Sphingolipids and expression regulation of genes in cancer.

Authors:  Gauri A Patwardhan; Yong-Yu Liu
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

4.  Forsythiaside protects against hydrogen peroxide-induced oxidative stress and apoptosis in PC12 cell.

Authors:  ChunKang Huang; Yonglian Lin; Hong Su; Dongqing Ye
Journal:  Neurochem Res       Date:  2014-10-25       Impact factor: 3.996

Review 5.  Mitochondrial targeted peptides for cancer therapy.

Authors:  Sadaf Farsinejad; Zohre Gheisary; Sanaz Ebrahimi Samani; Ali Mohammad Alizadeh
Journal:  Tumour Biol       Date:  2015-07-05

6.  Glutaredoxin 2 prevents H(2)O(2)-induced cell apoptosis by protecting complex I activity in the mitochondria.

Authors:  Hongli Wu; Kuiyi Xing; Marjorie F Lou
Journal:  Biochim Biophys Acta       Date:  2010-06-12

Review 7.  Programmed death in bacteria.

Authors:  K Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

8.  Protection from inactivation of the adenine nucleotide translocator during hypoglycaemia-induced apoptosis by mitochondrial phospholipid hydroperoxide glutathione peroxidase.

Authors:  Hirotaka Imai; Tomoko Koumura; Ryo Nakajima; Kazuhiro Nomura; Yasuhito Nakagawa
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line.

Authors:  Jiwon Chang; Hak Hyun Jung; Ji Yoon Yang; Sehee Lee; June Choi; Gi Jung Im; Sung Won Chae
Journal:  J Assoc Res Otolaryngol       Date:  2013-12-03

Review 10.  Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.

Authors:  Gang Cheng; Rong-hua Kong; Lei-ming Zhang; Jian-ning Zhang
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.